PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Study assesses cancer-related care at US hospitals predominantly serving minority populations compared with non-minority serving hospitals

Analysis reveals systemic disparities in the delivery of definitive cancer treatment.

2024-05-27
(Press-News.org) It’s important to ensure that care provided at US hospitals that predominantly serve Black and Hispanic populations is as high-quality as the care provided at other US hospitals. New research reveals significant disparities in the delivery of cancer-related care at minority serving hospitals (MSHs) compared with non-MSHs, however. The findings are published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society.

For the study, investigators analyzed information from the National Cancer Database (which accrues approximately 70% of US cancer diagnoses) to identify patients eligible for definitive treatment for breast, prostate, non-small cell lung, and colon cancers between 2010 and 2019. Definitive treatment was defined as surgery for breast and colon cancer; surgery, radiation, or ablation for prostate cancer; and surgery or radiation for non-small cell lung cancer.

Of approximately 2.9 million patients who received care at 1,330 hospitals between 2010 and 2019, 9.3% were treated at MSHs. Among patients with breast cancer, those treated at MSHs were 17% less likely to receive definitive cancer treatment. For prostate, lung, and colon cancer, those treated at MSHs were 31%, 27%, and 19% less likely to receive definitive treatment respectively. These disparities persisted even after accounting for various sociodemographic and clinical factors.

The study’s authors calculated that if efforts successfully improved treatment rates at MSHs to match those at non-MSHs, 5,719 additional patients would receive definitive cancer treatment over 10 years. Providing additional funding and targeted improvements to hospitals without adequate resources may be important steps towards reaching this goal and could help to reduce racial and ethnic disparities in cancer outcomes.

“Access to care is a significant factor contributing to racial differences in cancer mortality, alongside biological differences. Therefore, improving services at hospitals that primarily serve minority populations could be a crucial part of a wider effort to achieve healthcare equity,” said lead author Quoc-Dien Trinh, MD, MBA, of Brigham and Women’s Hospital. 

 

Additional information
NOTE: The information contained in this release is protected by copyright. Please include journal attribution in all coverage. A free abstract of this article will be available via the CANCER Newsroom upon online publication. For more information or to obtain a PDF of any study, please contact: Sara Henning-Stout, newsroom@wiley.com

Full Citation:
“Estimating the Impact of Enhanced Care at Minority-Serving Hospitals on Disparities in the Treatment of Breast, Prostate, Lung, and Colon Cancers.” Edoardo Beatrici, Marco Paciotti, David-Dan Nguyen, Dejan K. Filipas, Zhiyu Qian, Giovanni Lughezzani, Danesha Daniels, Stuart R. Lipsitz, Adam S. Kibel, Alexander P. Cole, and Quoc-Dien Trinh. CANCER; Published Online: May 27, 2024 (DOI: 10.1002/cncr.35328). 

URL Upon Publication: http://doi.wiley.com/10.1002/cncr.35328

Author Contact: Brigham and Women’s Hospital’s External Communications & Media Relations office, at mediarelations@bwh.harvard.edu

About the Journal 
CANCER is a peer-reviewed publication of the American Cancer Society integrating scientific information from worldwide sources for all oncologic specialties. The objective of CANCER is to provide an interdisciplinary forum for the exchange of information among oncologic disciplines concerned with the etiology, course, and treatment of human cancer. CANCER is published on behalf of the American Cancer Society by Wiley and can be accessed online. Follow CANCER on Twitter @JournalCancer and Instagram @ACSJournalCancer, and stay up to date with the American Cancer Society Journals on LinkedIn.

About Wiley      
Wiley is a knowledge company and a global leader in research, publishing, and knowledge solutions. Dedicated to the creation and application of knowledge, Wiley serves the world’s researchers, learners, innovators, and leaders, helping them achieve their goals and solve the world's most important challenges. For more than two centuries, Wiley has been delivering on its timeless mission to unlock human potential.  Visit us at Wiley.com. Follow us on Facebook, Twitter, LinkedIn and Instagram.

END


ELSE PRESS RELEASES FROM THIS DATE:

First in-human investigator-initiated clinical trial to launch for refractory prostate cancer patients: Novel alpha therapy targets prostate-specific membrane antigen

First in-human investigator-initiated clinical trial to launch for refractory prostate cancer patients: Novel alpha therapy targets prostate-specific membrane antigen
2024-05-27
Osaka, Japan - A research team at Osaka University will start an investigator-initiated clinical trial for refractory prostate cancer patients after successful development of a new alpha-ray therapeutic agent ([At-211] PSMA-5) and confirmation of its efficacy in animal models. This will be a world-first in-human clinical trial with [At-211] PSMA-5. Prostate cancer is on the rise worldwide and is the most commonly diagnosed new cancer in men in Japan. Various treatments are offered for prostate cancer, but the prognosis is very poor when the disease is resistant to standard treatment and associated with multiple metastases. In ...

Will generative AI change the way universities communicate?

2024-05-27
Since the launch of ChatGPT 3 in November 2022, we've been abuzz with talk of artificial intelligence: is it an unprecedented opportunity, or will it rob everyone of jobs and creativity? As we debate on social media (and perhaps use ChatGPT almost daily), generative AIs have also entered the arena of university communication. These tools—based on “Large Language Models” that were optimized for interactive communication—can indeed support, expand, and innovate university communication ...

Artificial Intelligence could help cure loneliness, says expert

2024-05-27
Artificial Intelligence (AI) technology could offer companionship to lonely people amid an international epidemic of loneliness, says a robotics expert. Tony Prescott, a professor of cognitive robotics at the University of Sheffield, argues in his new book The Psychology of Artificial Intelligence that ‘relationships with AIs could support people’ with forms of social interaction.. Loneliness has been found to seriously impair human health, and Professor Prescott makes a case that advances in AI technology could ...

Echidnapus identified from an ‘Age of Monotremes’

Echidnapus identified from an ‘Age of Monotremes’
2024-05-26
Published today in the Alcheringa: An Australasian Journal of Palaeontology, evidence of an ‘Age of Monotremes’ has been unearthed by a team of Australian scientists at the Australian Museum (AM), Museums Victoria and Australian Opal Centre. The findings were led by two renowned mammalogists, Honorary Associate of the Australian Museum, Professor Tim Flannery; and Professor Kris Helgen, Chief Scientist and Director of the Australian Museum Research Institute (AMRI). Found in the Lightning Ridge opal fields, NSW, the opalised jaws ...

Semaglutide may protect kidney function in individuals with overweight or obesity and cardiovascular disease

2024-05-25
The SELECT Trial has revealed the potential of semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in combating kidney function decline among individuals with overweight or obesity and established cardiovascular disease but without diabetes.1 Unveiling the results today at the 61st ERA Congress, researchers presented the impressive secondary analysis from the SELECT (Semaglutide Effects on Heart Disease and Stroke in Patients with Overweight or Obesity) trial, a randomised trial comprising a participant pool of 17,604 individuals. Experts believe the study’s results offer hope for those affected by obesity, a condition known ...

New technique detects novel biomarkers for kidney diseases with nephrotic syndrome

2024-05-25
A groundbreaking study, presented today at the 61st ERA Congress, has uncovered a significant breakthrough in the diagnosis and monitoring of kidney diseases associated with nephrotic syndrome.1 Using a hybrid technique, researchers identified anti-nephrin autoantibodies as a reliable biomarker for tracking disease progression, opening new avenues for personalised treatment approaches. Nephrotic syndrome, characterised by elevated protein levels in the urine, is linked to kidney diseases such as minimal change disease (MCD), primary focal segmental glomerulosclerosis (FSGS), and membranous nephropathy (MN). The primary cause behind nephrotic syndrome is damage to podocytes, the ...

Political elites take advantage of anti-partisan protests to disrupt politics

Political elites take advantage of anti-partisan protests to disrupt politics
2024-05-24
Protest movements that reject political parties have an unintended consequence, according to new research from the University of Notre Dame: They empower savvy politicians who channel them to shake up the status quo. The findings provide a framework for understanding recent global political realignments and offer lessons for activists who want to make a meaningful impact. They are particularly relevant in an era when mass protests have become an increasingly common tool to voice dissent with powerful institutions and draw attention to overlooked issues ranging from climate and conflict ...

Tiny target discovered on RNA to short-circuit inflammation, UC Santa Cruz researchers find

Tiny target discovered on RNA to short-circuit inflammation, UC Santa Cruz researchers find
2024-05-24
UC Santa Cruz researchers have discovered a peptide in human RNA that regulates inflammation and may provide a new path for treating diseases such as arthritis and lupus. The team used a screening process based on the powerful gene-editing tool CRISPR to shed light on one of the biggest mysteries about our RNA–the molecule responsible for carrying out genetic information contained in our DNA. This peptide originates from within a long non-coding RNA (lncRNA) called LOUP. According to the researchers, ...

Charge your laptop in a minute? Supercapacitors can help; new research offers clues

2024-05-24
Imagine if your dead laptop or phone could charge in a minute or if an electric car could be fully powered in 10 minutes. While not possible yet, new research by a team of CU Boulder scientists could potentially lead to such advances.  Published today in the Proceedings of the National Academy of Sciences, researchers in Ankur Gupta’s lab discovered how tiny charged particles, called ions, move within a complex network of minuscule pores. The breakthrough could lead to the development of more efficient energy storage devices, such as supercapacitors, said Gupta, an assistant professor of chemical and biological engineering.  “Given the critical role ...

Scientists discover CO2 and CO ices in outskirts of solar system

2024-05-24
ORLANDO, May 24, 2024 – For the first time, carbon dioxide and carbon monoxide ices have been observed in the far reaches of our solar system on trans-Neptunian objects (TNOs). A research team, led by planetary scientists Mário Nascimento De Prá and Noemí Pinilla-Alonso from the University of Central Florida’s Florida Space Institute (FSI), made the findings by using the infrared spectral capabilities of the James Webb Space Telescope (JWST) to analyze the chemical composition of 59 trans-Neptunian objects and Centaurs. The pioneering study, published ...

LAST 30 PRESS RELEASES:

ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial

ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer

ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

Continuous and fixed-duration treatments result in similar outcomes for CLL

Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia

Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease

Roughly one-third of families with children being treated for leukemia struggle to pay living expenses

Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy

IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection

Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients

Emergency departments fall short on delivering timely treatment for sickle cell pain

Study shows no clear evidence of harm from hydroxyurea use during pregnancy

Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease

Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia

Early results suggest exa-cel gene therapy works well in children

NTIDE: Disability employment holds steady after data hiatus

Social lives of viruses affect antiviral resistance

Dose of psilocybin, dash of rabies point to treatment for depression

Helping health care providers navigate social, political, and legal barriers to patient care

Barrow Neurological Institute, University of Calgary study urges “major change” to migraine treatment in Emergency Departments

Using smartphones to improve disaster search and rescue

Robust new photocatalyst paves the way for cleaner hydrogen peroxide production and greener chemical manufacturing

Ultrafast material captures toxic PFAS at record speed and capacity

Plant phenolic acids supercharge old antibiotics against multidrug resistant E. coli

UNC-Chapel Hill study shows AI can dramatically speed up digitizing natural history collections

OYE Therapeutics closes $5M convertible note round, advancing toward clinical development

Membrane ‘neighborhood’ helps transporter protein regulate cell signaling

Naval aviator turned NPS doctoral student earns national recognition for applied quantum research

Astronomers watch stars explode in real time through new images

[Press-News.org] Study assesses cancer-related care at US hospitals predominantly serving minority populations compared with non-minority serving hospitals
Analysis reveals systemic disparities in the delivery of definitive cancer treatment.